6818 related articles for article (PubMed ID: 2962476)
21. Circulating immune complexes in cancer patients.
Jaramillo S; Shafir M; Bekesi G
Immunol Invest; 1987 Aug; 16(5):383-98. PubMed ID: 3692551
[TBL] [Abstract][Full Text] [Related]
22. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
23. Pilot studies using melanoma tumor-associated antigens (TAA) in specific-active immunochemotherapy of malignant melanoma.
Hollinshead A; Arlen M; Yonemoto R; Cohen M; Tanner K; Kundin WD; Scherrer J
Cancer; 1982 Apr; 49(7):1387-404. PubMed ID: 7059953
[TBL] [Abstract][Full Text] [Related]
24. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of circulating immune complexes in cancer patients.
Dass TK; Aziz M; Rattan A
Jpn J Cancer Res; 1991 Nov; 82(11):1284-91. PubMed ID: 1752784
[TBL] [Abstract][Full Text] [Related]
26. Comparison of antibody isotypes in sera and circulating immune complexes during tumor growth and metastasis of three tumor models in mice.
McDonald TL; Collins M; Talmadge JE
Cancer Res; 1984 Nov; 44(11):4933-7. PubMed ID: 6435859
[TBL] [Abstract][Full Text] [Related]
27. Assay, isolation and characterization of circulating immune complexes from serum of gastrointestinal cancer, stage III and IV melanoma and chronic inflammatory bowel disease patients.
Bartoloni C; Guidi L; Pili R; Lewis ZA; Tricerri A; Cursi F; Gentiloni N; Cortesi E; Gambassi G
Oncology; 1993; 50(1):27-34. PubMed ID: 8421596
[TBL] [Abstract][Full Text] [Related]
28. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
[TBL] [Abstract][Full Text] [Related]
29. Significance of circulating HBs antigen-antibody immune complexes in patients with HBs antigen-positive liver disease.
Sugiura K; Hasumura Y; Takeuchi J
Gastroenterol Jpn; 1982; 17(3):241-5. PubMed ID: 7117781
[TBL] [Abstract][Full Text] [Related]
30. Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine.
Hsueh EC; Gupta RK; Qi K; Morton DL
J Clin Oncol; 1998 Sep; 16(9):2913-20. PubMed ID: 9738558
[TBL] [Abstract][Full Text] [Related]
31. The nature of immune complexes in human cancer sera.
Theofilopoulos AN; Andrews BS; Urist MM; Morton DL; Dixon FJ
J Immunol; 1977 Aug; 119(2):657-63. PubMed ID: 886189
[TBL] [Abstract][Full Text] [Related]
32. Detection and isolation of antigen-specific immune complexes from sera of melanoma patients.
Wong JH; Xu SH; Saxton RE; Gupta RK; Morton DL
Int J Cancer; 1990 Mar; 45(3):445-9. PubMed ID: 1689702
[TBL] [Abstract][Full Text] [Related]
33. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
Koestler TP; Papsidero LD; Nemoto T; Chu TM
Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
[TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of circulating immune complexes in patients with metastatic breast cancer].
Krieger G; Kehl A; Bause I; Kneba M; Nagel GA
Klin Wochenschr; 1982 Dec; 60(23):1465-72. PubMed ID: 7154620
[TBL] [Abstract][Full Text] [Related]
35. [Cholesterol-containing circulating immune complexes--a component of the blood serum in patients with ischemic heart disease that determines its atherogenic properties].
Tertov VV; Kacharava AG; Saiadian KhS; Serebrennikov SG; Liakishev AA; Kozlov SG; Gratsianskiĭ NA; Rogova EM; Bocharova OI; Orekhov AN
Kardiologiia; 1989 Aug; 29(8):35-8. PubMed ID: 2479794
[TBL] [Abstract][Full Text] [Related]
36. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
37. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
[TBL] [Abstract][Full Text] [Related]
38. Analysis of antigen involved in circulating immune complexes in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Hayashi S; Aochi H; Nagamine K; Oshida M; Mizutani H; Tomiyama Y; Tsubakio T; Yonezawa T; Tarui S
Clin Exp Immunol; 1987 Feb; 67(2):293-9. PubMed ID: 3608226
[TBL] [Abstract][Full Text] [Related]
39. Prospective evaluation of the use of antigen-specific immune complexes in predicting the development of recurrent melanoma.
Wong JH; Xu SH; Skinner KA; Foshag LJ; Morton DL
Arch Surg; 1991 Dec; 126(12):1450-4. PubMed ID: 1842173
[TBL] [Abstract][Full Text] [Related]
40. Antigen/antibody content of circulating immune complexes in HIV-infected patients.
Stanojevic M; Zerjav S; Jevtovic D; Markovic L
Biomed Pharmacother; 1996; 50(10):488-93. PubMed ID: 9091062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
